| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 66.98B | 71.73B | 64.88B | 53.30B | 45.95B | 36.51B |
| Gross Profit | 21.19B | 22.58B | 20.55B | 18.20B | 16.37B | 12.46B |
| EBITDA | 9.82B | 10.55B | 9.59B | 8.19B | 7.58B | 6.15B |
| Net Income | 4.19B | 5.18B | 4.06B | 3.54B | 2.95B | 2.37B |
Balance Sheet | ||||||
| Total Assets | 107.63B | 121.53B | 105.44B | 89.63B | 65.69B | 52.50B |
| Cash, Cash Equivalents and Short-Term Investments | 29.20B | 35.80B | 27.33B | 27.27B | 20.07B | 18.16B |
| Total Debt | 5.32B | 4.17B | 5.60B | 4.17B | 4.65B | 3.50B |
| Total Liabilities | 77.70B | 88.85B | 75.44B | 62.58B | 41.77B | 32.30B |
| Stockholders Equity | 24.11B | 26.33B | 24.21B | 21.74B | 18.97B | 17.02B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 12.03B | 6.15B | 8.10B | 4.87B | 4.87B |
| Operating Cash Flow | 0.00 | 13.14B | 6.84B | 8.98B | 6.35B | 5.28B |
| Investing Cash Flow | 0.00 | -1.13B | -5.96B | -1.94B | -2.18B | 195.69M |
| Financing Cash Flow | 0.00 | -3.63B | -799.03M | 147.56M | -2.25B | -1.96B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥74.33B | 3.15 | ― | 3.28% | 12.54% | 171.52% | |
74 Outperform | ¥74.99B | 13.80 | 17.96% | 1.83% | 10.56% | 27.45% | |
74 Outperform | ¥84.08B | 13.83 | ― | 2.32% | 8.80% | 16.40% | |
71 Outperform | ¥152.20B | 13.05 | ― | 2.30% | 12.89% | 36.13% | |
68 Neutral | ¥140.71B | 13.67 | 11.52% | 2.76% | 4.79% | 15.28% | |
65 Neutral | ¥30.39B | 20.84 | 10.34% | 4.82% | -2.76% | 36.33% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |